What is BB Biotech AG (BBAGF)?

BB Biotech AG (BBAGF) is a stock in the Financial Services sector, Financial - Conglomerates industry. View full analysis on Stocks360.

What is the current price of BBAGF?

The current price of BBAGF is $55.00. Prices are updated in real time on Stocks360.

What is BBAGF's price-to-earnings (PE) ratio?

BBAGF's trailing twelve-month PE ratio is 2.11, based on current price and earnings per share data available on Stocks360.

What is BBAGF's market capitalization?

BBAGF's market capitalization is $4,223,659,110.00, placing it in the mid-cap tier.

Does BBAGF pay a dividend?

Yes. BBAGF has a trailing twelve-month dividend yield of 0.04%. Dividend data is sourced from financial market providers and displayed on Stocks360.

BB Biotech AG (BBAGF)

Stock analysis · OTC · Financial Services · Financial - Conglomerates

$55.00

Market Cap

$4.22B

PE (TTM)

2.11

EPS (TTM)

N/A

Dividend Yield

4.34%

Beta

0.57

Day Range

$55.00 – $55.00

52-wk Range

$33.65 – $61.55

Avg Volume

N/A

Volume

0.00

BB Biotech AG (BBAGF) is a publicly traded company in the Financial Services sector. Latest price: $55.00. Market cap $4.22B. Trailing PE 2.11. Dividend yield 4.34%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-09-15 · $76.06 2026-08-12 · $76.06 (+0.00%)

Earnings

Most Recent

Feb 16, 2024

EPS $2.33 vs est. $-0.76

Beat by $3.09

Next Earnings

Oct 23, 2026

EPS estimate $0.00

Proprietary Signals

Signal snapshot temporarily unavailable.

About BB Biotech AG

BB Biotech AG provides investment services for biotechnology sector. It invests in portfolio of companies that are engaged in developing and marketing of innovative biotech drugs. It offers investors a exposure to a focused portfolio of predominantly-US small-to-mid-cap biotech companies developing therapeutic products, towards cell, gene and particularly RNA-based technologies. The company was founded on November 9, 1993 and is headquartered in Schaffhausen, Switzerland.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	2.11×
P/S (TTM)	19.57×
P/B	0.93×
PEG	0.00×
P/FCF (TTM)	9.43×
EV / EBITDA	1.97×
EV / Sales	18.17×
Earnings Yield	47.23%
Free Cash Flow Yield	10.60%
Dividend Yield	4.34%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$2.65B
Revenue (TTM)	$146.00M
Net Income (TTM)	$1.35B
Free Cash Flow (TTM)	$302.78M
Net Debt	-$203.76M
Working Capital	$3.09B
Gross Margin	100.00%
Operating Margin	924.92%
Net Margin	924.03%
Return on Equity	49.95%
Return on Invested Capital	43.70%